Compounds > mechlorethamine
Page last updated: 2024-10-30

mechlorethamine and Multiple Endocrine Neoplasia Type 1

mechlorethamine has been researched along with Multiple Endocrine Neoplasia Type 1 in 1 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Multiple Endocrine Neoplasia Type 1: A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busygina, V1
Suphapeetiporn, K1
Marek, LR1
Stowers, RS1
Xu, T1
Bale, AE1

Other Studies

1 other study available for mechlorethamine and Multiple Endocrine Neoplasia Type 1

ArticleYear
Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1.
    Human molecular genetics, 2004, Oct-15, Volume: 13, Issue:20

    Topics: Animals; Cisplatin; Cross-Linking Reagents; Disease Models, Animal; Drosophila; Drosophila Proteins;

2004